CRH Medical Corp (NYSEARCA:CRHM) has been assigned an average recommendation of “Buy” from the nine analysts that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $7.50.

Several research firms recently issued reports on CRHM. Zacks Investment Research cut shares of CRH Medical Corp from a “hold” rating to a “sell” rating in a report on Tuesday, April 11th. Scotiabank cut shares of CRH Medical Corp from an “outperform” rating to a “sector perform” rating in a report on Friday, July 14th. CIBC cut shares of CRH Medical Corp from a “sector outperform” rating to a “sector perform” rating in a report on Monday, July 17th. Canaccord Genuity reaffirmed a “buy” rating and issued a $8.00 price target on shares of CRH Medical Corp in a report on Monday, July 17th. Finally, TD Securities cut shares of CRH Medical Corp from a “buy” rating to a “hold” rating in a report on Tuesday, July 18th.

WARNING: This report was originally posted by Daily Political and is owned by of Daily Political. If you are reading this report on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The original version of this report can be viewed at https://www.dailypolitical.com/2017/08/08/crh-medical-corp-crhm-given-average-recommendation-of-buy-by-brokerages.html.

A number of hedge funds have recently added to or reduced their stakes in the stock. ARP Americas LLC raised its position in CRH Medical Corp by 7.4% in the first quarter. ARP Americas LLC now owns 13,042 shares of the company’s stock valued at $107,000 after buying an additional 900 shares in the last quarter. Tower Research Capital LLC TRC raised its position in CRH Medical Corp by 15,344.4% in the first quarter. Tower Research Capital LLC TRC now owns 13,900 shares of the company’s stock valued at $114,000 after buying an additional 13,810 shares in the last quarter. Acadian Asset Management LLC purchased a new position in CRH Medical Corp during the first quarter valued at approximately $150,000. KCG Holdings Inc. raised its position in CRH Medical Corp by 40.1% in the first quarter. KCG Holdings Inc. now owns 19,486 shares of the company’s stock valued at $160,000 after buying an additional 5,579 shares in the last quarter. Finally, Navellier & Associates Inc purchased a new position in CRH Medical Corp during the first quarter valued at approximately $198,000.

Shares of CRH Medical Corp (CRHM) opened at 2.60 on Tuesday. CRH Medical Corp has a 12 month low of $2.50 and a 12 month high of $9.25. The firm has a 50 day moving average of $4.77 and a 200-day moving average of $6.37.

CRH Medical Corp Company Profile

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical Corp (NYSEARCA:CRHM)

Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.